Picciotto to be Recognized with Marion Spencer Fay Award
The Institute for Women’s Health and Leadership of Drexel University College of Medicine will award its 2020 Marion Spencer Fay Award to Marina Picciotto, PhD, Charles B.G. Murphy Professor of Psychiatry and Professor in the Child Study Center, of Neuroscience and of Pharmacology at Yale School of Medicine.
Yale Cancer Center and Smilow Cancer Hospital physicians recognized as CT Magazine 'Best Doctors'
Connecticut Magazine has named 72 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2019 Best Doctors guide. Published in the magazine’s June issue, the Best Doctors list consists of 782 Connecticut physicians from 78 medical specialties.
New strategy for untreatable kidney disease: targeting cell energy
The best hope for people with an inherited form of kidney disease that causes kidney failure is dialysis or a kidney transplant. But a study led by Yale researchers reveals a potential strategy for developing new drug therapies for these patients.
$20 Million Grant Will Fund Continued Research by Yale Tobacco Center of Regulatory Science
The National Institute of Health and the U.S. Food and Drug Administration have renewed a $20 million grant for the Yale Tobacco Center of Regulatory Science (TCORS) to continue to investigate the influence of flavors and sweeteners, and other constituents, on the appeal and addictive potential of traditional tobacco products and newer products like e-cigarettes.
Your Teen Is Underestimating the Health Risks of Vaping
According to the FDA, teenage use of e-cigarettes has reached “an epidemic proportion.” Eleven percent of high school seniors, 8 percent of tenth graders, and 3.5 percent of eighth graders reported vaping with nicotine in the past month, according to a national survey released from the University of Michigan late last year. The worrying part? Young people think vaping is mostly harmless. Our Yale Medicine experts explain vaping, the potential dangers associated with it, and how to talk to your teen about it.
New university report recommends science priorities for the decade ahead
A university committee has made strategic recommendations to bolster Yale’s position as a leading global research university and nurture scientific discoveries with the potential to improve the world. The report recommends bold priorities for investment and changes to organizational structure.
Researchers develop novel immunotherapy to target colorectal cancer
A Yale-led research team has developed an antibody that blocks tumors in animal models of colorectal cancer. If the finding is confirmed in clinical trials, the antibody-based treatment could become an effective weapon against colorectal cancer, and possibly other cancers, that resist current immunotherapies, the researchers said.
Blavatnik Fund awards grants for innovation
Several faculty members won research grants from the Blavatnik Fund for Innovation at Yale at the fourth annual Yale Innovation Summit on May 10. The summit, presented by the Office of Cooperative Research (OCR) and Yale Entrepreneurial Institute, provides a window into an expanding entrepreneurial ecosystem at Yale.
Finalists Named for the Blavatnik Fund Highlighting Promising Research Across Yale
Seventeen applications from Yale innovators have been named finalists for grants and resources from the Blavatnik Fund for Innovation at Yale, competing for up to $300,000 in Development grants or up to $100,000 in Pilot grants to accelerate their life science research into the marketplace. The $10 million fund supported by the Blavatnik Family Foundation launched this year to advance entrepreneurship in the life sciences at Yale and is managed by the Yale Office of Cooperative Research. Over 60 researchers applied for funding from across the Yale science disciplines, including chemistry, pharmacology, neuroscience, biomedical engineering, obstetrics, biophysics and immunobiology.
Can a cancer drug treat a rare cardiac disease?
A study by a Yale scientis suggests that dasatinib and similar drugs at low doses could be effective treatment for cardiovascular defects related to Noonan syndrome (NS), a genetic disorder that results in severe heart defects, and should be considered for clinical trials.
Study finds key protein that binds to LDL cholesterol
A Yale-led research team identified a protein that plays an important role in the buildup of LDL cholesterol in blood vessels. The finding could lead to an additional strategy to block LDL accumulation, which could help prevent or slow the clogging of arteries that leads to heart disease, the researchers said.